Project Grant R21TR005475
Award Date
7/7/25
Completion Date
6/30/27
Dollars Obligated
$419K
Federal Agency
National Center for Advancing Translational Sciences
Federal Grant Program
93.350
Assistance Type
Project Grant
Place of Performance
Florida, USA
Similar Awards
The University of Florida (UF) Division of Sponsored Research has been awarded a $2,235,400 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The award, effective April 1, 2024 through March 31, 2028, will support research on the "Contribution of Repeat Associated Non-AUG (RAN) Proteins in Friedreich's and Other Hereditary Ataxias." This project grant is part of the Military Medical Research and Development program, which...
The University of Florida was awarded a $3.86 million Project Grant from the National Institute on Aging, part of the National Institutes of Health within the Department of Health and Human Services. The grant falls under the Aging Research program (CFDA 93.866), which supports biomedical, social and behavioral research on aging. The three-year grant will fund research to test the hypothesis that novel types of repeat-associated non-AUG (RAN) proteins contribute to amyotrophic lateral...
The University of Florida Division of Sponsored Research was awarded a $745,408 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on April 1, 2024, will support research on the "Contribution of Repeat Associated Non-AUG (RAN) Proteins in Friedreich's and Other Hereditary Ataxias" over a 4-year period through March 31, 2028. This research aims to advance the understanding and...
This $1,525,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports foundational studies at the University of Florida to understand the phenotypic, region-specific, and cell-specific dysregulation in the central nervous system of individuals with myotonic dystrophy. The 4-year award, effective May 15, 2024, will enable the university to conduct innovative research to advance the understanding of this neurological...
This federal Project Grant award, valued at $419,398, was provided by the National Center for Advancing Translational Sciences (NCATS) under the CFDA Program 93.350 to accelerate the translation of oligonucleotide therapeutics by enhancing delivery. The project aims to develop a small molecule solution to improve the delivery of systemically administered oligonucleotide therapeutics to extrahepatic tissues, a critical unmet need that has limited the broad clinical translation of these...
The University of Florida was awarded a $5.796 million Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of September 1, 2023 through August 31, 2027. The grant will support the development of clinical candidates for the treatment of Myotonic Dystrophy at the University's location in Gainesville, Florida. As the prime awardee, the University will leverage its expertise in biomedical research to...
The University of Florida (UF) received a $1,524,836 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on understanding and targeting common mechanisms of myotonic dystrophy types 1 and 2 using novel repeat expansion mouse models. The grant, which began on September 1, 2023 and will continue through August 31, 2027, supports UF's cutting-edge biomedical research efforts to transform healthcare for Service...
The University of Florida was awarded a $305,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 2021 through March 2024 to develop novel therapies for dystonia. Through this funding, the University of Florida Division of Sponsored Research will conduct research into medical solutions for dystonia that can potentially transform healthcare for service members and the...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $796,875 project grant to the University of Florida (UF) Division of Sponsored Research. The grant, awarded on April 1, 2024, supports the development of heterobifunctional degraders of TDP-43 as a novel therapeutic strategy for amyotrophic lateral sclerosis (ALS). Under this grant, the University of North Carolina at Chapel Hill (UNC-CH) Office of Sponsored Research is serving as a sub-awardee....
This $305,000 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will support research at the University of Florida to investigate the effects of GRN gene mutations on motor and language deficits associated with frontotemporal dementia (FTD). The key objectives are to: Examine motor and non-motor behavioral deficits in a mouse model with striatum-specific GRN knockout. Analyze changes in striatal neuron properties, cholinergic interneurons, and...